FDA warning on home diagnostic kits
This article was originally published in The Tan Sheet
Executive Summary
Pregnancy Test and Rapid HIV Test Kit marketed by the Canadian firm Globus Media are among the unapproved diagnostic products being sold by the company and should not be purchased, FDA says in a Feb. 7 consumer warning. The other six illegal kits are an HCG urine test and tests for syphilis, cocaine, marijuana, amphetamine and dengue fever. Use of the kits may produce false results that could "lead to significant adverse health consequences" if those who test negative do not seek medical treatment or spread a virus to others, the agency notes. The tests have been marketed nationwide through websites. Anyone who has used one of the kits "should be retested using valid test methods," FDA says...
You may also be interested in...
OraSure Seeks Regulatory Feedback For Marketing Home-Use HIV Test
OraSure Technologies will seek guidance from FDA's Blood Product's Advisory Committee on making its OraQuick Advance oral fluid HIV test available over the counter for use in the home
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.